Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2002, p. 1781-1784, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.1781-1784.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Precision and Accuracy of Fluconazole Susceptibility Testing by Broth Microdilution, Etest, and Disk Diffusion Methods
A. L. Barry,1* M. A. Pfaller,2 R. P. Rennie,3 P. C. Fuchs,1 and S. D. Brown1
The Clinical Microbiology Institute, Wilsonville, Oregon,1
University of Iowa College of Medicine, Iowa City, Iowa,2
National Center for Mycology, Edmonton, Alberta, Canada3
Received 29 November 2001/
Returned for modification 11 January 2002/
Accepted 5 March 2002

ABSTRACT
Interpretive agreements among the results of fluconazole broth
microdilution tests, Etests, and disk diffusion tests were documented
by evaluating 495
Candida spp. Microdilution reference test
results were in agreement with 96% of the Etest results; most
discrepancies were minor differences. Fluconazole resistance
of
Candida krusei strains often required a full 48 h of incubation
in order to be observed by the standard method. For the disk
diffusion tests that were performed on Mueller-Hinton agar with
glucose and methylene blue, 97% of results were in agreement
with those of the reference test, especially when zones of inhibition
were measured after the first 24 h of incubation. Some
Candida glabrata isolates failed to grow satisfactorily until a full
48 h of incubation was completed. Precision was determined by
testing 50 selected isolates in triplicate in each of three
laboratories. The reproducibility of results of disk diffusion
tests was comparable to that of the reference method. With all
procedures, determination of test results was particularly challenging
with some strains, and new methods are needed in order to improve
endpoint definition.

INTRODUCTION
Compromised patients, such as those infected with human immunodeficiency
virus, are often colonized by and/or infected with fungi, especially
Candida spp. Consequently, they frequently receive antifungal
agents such as fluconazole for relatively long periods of time
during hospitalization. Prolonged exposure to an azole such
as fluconazole can select strains with diminished susceptibilities
(
6,
7), and consequently, increasing doses may be necessary.
For this reason, the susceptibilities of isolates recovered
from compromised patients receiving prolonged fluconazole treatment
should be monitored in order to determine when strains with
decreased susceptibilities have been selected (
3). In order
to do this in a cost-effective way, simple, inexpensive testing
procedures are needed, but such tests must be accurate and precise.
The purpose of this report is to document the relative levels
of accuracy and precision of three procedures for testing fluconazole:
broth microdilution, Etest, and disk diffusion. The accuracy
of each procedure was assessed by comparing the results to those
obtained by the 48-h microdilution reference method of the National
Committee for Clinical Laboratory Standards (NCCLS) (
8). Precision
was measured by performing replicate tests in three separate
laboratories.

MATERIALS AND METHODS
Microorganisms.
For this study, M. A. Pfaller selected 495 clinical isolates
of
Candida spp. for which there was a broad range of fluconazole
MICs. The five species that were represented are shown in Table
1. For testing reproducibility, 50 of the 495 isolates were
selected in order to maximize the number of strains for which
MICs were near the interpretive breakpoints of

8.0 µg/ml
(susceptible) and

64 µg/ml (resistant). This subset of
strains included 26 strains of
Candida albicans and 6 strains
each of
Candida glabrata,
Candida krusei,
Candida parapsilosis,
and
Candida tropicalis. Quality control strains of
C. parapsilosis (ATCC 22019) and
C. krusei (ATCC 6258) were included in every
test run.
View this table:
[in this window]
[in a new window]
|
TABLE 1. Susceptibility of 495 Candida spp. isolates to fluconazole as determined by two different methods and two incubation times
|
Microdilution susceptibility tests.
The NCCLS procedure (
8) was followed as carefully as possible.
Serial dilutions of fluconazole (from 256 to 0.03 µg/ml)
were prepared in RPMI 1640 broth (HyClone lot no. AHC 7888A)
and then dispensed into microdilution test panels. The trays
were then stored at -70°C until needed. The inoculum was
adjusted to provide 0.5
x 10
3 to 2.5
x 10
3 CFU/ml (
4,
8,
9)
as confirmed by periodic colony counts throughout the study.
The trays were incubated at 35°C in ambient air. After 24
h and again after 48 h, MICs were recorded as the lowest concentrations
that were visually determined to result in substantial decreases
in the amount of growth (about 50 to 80% inhibition compared
to that in a growth control well). Quality control strains of
Candida spp. were evaluated throughout the study, and the fluconazole
MICs fell within the expected ranges (
2).
Agar-based susceptibility tests.
Etest strips (AB Biodisk, Solna, Sweden) were tested on RPMI 1640 broth with 2% glucose and 1.5% Bacto Agar (Difco Laboratories). For disk diffusion tests, 25-µg fluconazole disks (BBL lot no. 801553) were also applied to the same test plate. In addition, disk tests were also performed on Mueller-Hinton agar with 2% glucose and methylene blue (0.5 µg/ml). The latter reagent was added to help clarify the zone of inhibition. Because this medium gave encouraging results with disk tests in the initial phase of this study, it was added to the later evaluations of reproducibility. For either test, agar plates were swab inoculated with a suspension of yeast cells in a manner that is currently being used for testing antibacterial agents. When adjusted to the turbidity of a 0.5 McFarland standard, a suspension of yeasts contains about 106 CFU/ml (9). The diameter of each zone of inhibition was taken as the area that showed a sharp decline in the density of growth. Etest MICs were determined according to the manufacturer's instructions and were rounded up to the nearest even log2 concentration in order to simplify analysis.
Precision of test procedures.
A challenge set of 50 strains was selected, and each strain was subcultured to nine slants. These slants were then labeled with random code numbers, and three slants of each strain were distributed to the authors' laboratories. Broth microdilution trays, agar plates, 25-µg fluconazole disks, and Etest strips were provided by a common source. Each participant was asked to perform fluconazole susceptibility tests with subcultures of each of the 150 coded slants. In this way, triplicate tests were performed in a truly blind fashion that generated nine values for each strain. To evaluate the overall precision of each method, the median MIC or zone diameter was calculated and the reported results were evaluated in terms of the number of twofold dilution intervals away from the median MIC or the number of millimeters away from the median zone diameter for the strain.

RESULTS AND DISCUSSION
MICs.
Table
1 shows the MICs for each species as determined by microdilution
and Etest procedures and incubation for 24 or 48 h. The two
procedures gave MICs that were in general agreement (±
one or two doubling concentrations). For
C. albicans, C. tropicalis,
and
C. krusei, most Etest MICs were the same or 1 dilution higher
than those provided by microdilution tests. The reverse was
true when we tested
C. glabrata. With both methods, fluconazole
resistance among
C. krusei isolates was more apparent when the
isolates were incubated a full 48 h. For the purposes of this
study, the 48-h microdilution susceptibility test results (
8)
were used as the standard reference for evaluating other procedures.
Accuracy of tests.
All strains tested for susceptibility were interpreted as belonging to one of three categories (1, 8, 10): susceptible (strains for which MICs were
8 µg/ml or zone diameters were
19 mm), susceptible-dose dependent (strains for which MICs were 16 to 32 µg/ml or zone diameters were 15 to 18 mm), or resistant (strains for which MICs were
64 µg/ml or zone diameters were
14 mm). Percentages of results that were interpreted as being in agreement or discrepant were then calculated. Table 2 summarizes these estimates of accuracy for the different methods. When microdilution panels were observed after only 24 h of incubation, 98% of the strains had grown sufficiently to permit estimations of MICs and 94% of the MICs agreed with the results of the 48-h reference test. Very major discrepancies involved tests of C. krusei strains which were susceptible at 24 h but resistant at 48 h. This species also provided 20 of the 22 minor discrepancies.
View this table:
[in this window]
[in a new window]
|
TABLE 2. Overall interpretive agreement between results of fluconazole susceptibility tests and of standard 48-h broth microdilution reference tests
|
On RPMI 1640-glucose-agar, 94% of the strains grew sufficiently
to permit the recording of test results after 24 h. The majority
of early-growth failures involved tests of the
C. glabrata strains
that required a full 48 h for testing, and even then, the lawns
of growth were rather light. Etest MICs with this medium showed
96% agreement with the reference microdilution test results.
The majority of discrepancies were minor differences, but results
for two
C. krusei isolates showed very major discrepancies at
24 h. Results of disk diffusion tests on the same agar plates
displayed 93.5% agreement; all very major discrepancies involved
tests of
C. krusei, and results for two
C. albicans isolates
provided major discrepancies but only when they were read at
48 h.
Disk tests were improved by using Mueller-Hinton agar supplemented with glucose for better growth and a low concentration of methylene blue to help clarify the zones of inhibition. At the first 24 h, only five strains (three C. parapsilosis and two C. albicans strains) grew too poorly to permit measurement of zone diameters but they all grew sufficiently after 48 h. On this supplemented medium, results of the 24-h disk tests showed the best (97%) agreement with results of the 48-h broth microdilution test: only one very major discrepancy was recorded (C. krusei). The 14 minor discrepancies involved tests of eight C. krusei, three C. parapsilosis, two C. glabrata, and one C. albicans isolate . When disks were held for 48 h before inhibitory zones were measured, five isolates (three C. glabrata, one C. albicans, and one C. parapsilosis isolate) were judged to be "false resistant" (major errors). The few strains that grew poorly on the first day were accurately tested after an additional day of incubation. Figure 1 presents a scattergram plotted to compare the 24-h zones on this medium to the reference microdilution MICs for each of the 490 strains that grew sufficiently well.
Precision of MICs.
Table
3 summarizes data concerning the reproducibility of fluconazole
MICs. By the reference microdilution test, 93 to 94% of all
MICs varied over a broad range of ± two doubling concentrations
on either side of the median. This range of variation is in
agreement with observations made during the initial evaluation
of the microdilution procedure (
4). With the Etest, >90%
of all MICs were no more than one dilution interval from the
all-laboratory median. Compared to RPMI 1640-glucose-agar, Mueller-Hinton
agar with glucose and methylene blue did not improve the precision
of Etests. The reference method used to evaluate the other procedures
suffers from inconsistencies due largely to difficulties in
defining the endpoint when there is a trailing growth pattern.
The agar-based Etest (
5,
11) seems to have a slight advantage
over broth dilution tests in this regard. By both methods, MICs
recorded after 24 h were more consistent than those determined
after 48 h.
View this table:
[in this window]
[in a new window]
|
TABLE 3. Precision of fluconazole MICs when 50 Candida isolates were tested in triplicate in each of three laboratories
|
Precision of disk tests.
Table
4 describes the same type of data for disk diffusion tests.
From the regression statistics calculated from the data in Fig.
1, a twofold concentration change in MICs was accompanied by
a 3- to 4-mm change in the diameters of the zones of inhibition.
Consequently, the precision of disk tests can be compared to
that of MIC determinations. A range of MICs that represent the
median ± one doubling concentration is equal to a median
zone of ±3 or 4 mm, and a range of MICs that represent
the median ± two doubling concentrations is equal to
a median zone of ±6 to 8 mm. As can be seen in Table
4, the precision of disk diffusion tests is similar to that
observed for the standard reference procedure. When Mueller-Hinton
agar with glucose and methylene blue was used, the zone diameters
were more reproducible than those on RPMI 1640-glucose-agar.
Furthermore, zones of inhibition measured after 24 h of incubation
were more reproducible than those measured after 48 h.
We concluded that the results of fluconazole susceptibility
tests by the disk diffusion method were just as reproducible
as the results of the standard reference microdilution procedure.
Furthermore, of the tests that we evaluated, the Etest produced
the most reproducible results. The precision of disk diffusion
tests was maximized by using Mueller-Hinton agar with glucose
and methylene blue and by incubating the disks for only 24 h.
The 1% of strains that failed to grow adequately at the 24-h
examination gave satisfactory results when they were incubated
for another day. The results of disk diffusion tests done in
this way showed excellent (97%) agreement with the results of
the reference broth microdilution method.

ACKNOWLEDGMENTS
This study was made possible by a grant from Pfizer Pharmaceuticals,
New York, N.Y.

FOOTNOTES
* Corresponding author. Mailing address: The Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A-1, Wilsonville, OR 97070. Phone: (503) 682-3232. Fax: (503) 682-4548 or (503) 682-2065. E-mail:
cmi{at}hevanet.com.


REFERENCES
1
- Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.[Abstract]
2
- Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.[Abstract/Free Full Text]
3
- Bille, J. 1997. When should Candida isolates be tested for susceptibility to azole antifungal agents? Eur. J. Clin. Microbiol. Infect. Dis. 16:281-282.[CrossRef][Medline]
4
- Espinel-Ingroff, A., G. W. Kish, T. M. Kerkering, R. A. Fromtling, M. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.[Abstract/Free Full Text]
5
- Espinel-Ingroff, A., M. Pfaller, M. E. Erwin, and R. N. Jones. 1996. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J. Clin. Microbiol. 34:848-852.[Abstract]
6
- Fan-Harvard, P., D. Capano, S. M. Smith, A. Mangia, and R. H. K. Eng. 1991. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob. Agents Chemother. 35:2302-2305.[Abstract/Free Full Text]
7
- Korting, H. C., M. Ollert, A. Georgii, and M. Froschl. 1988. In vitro susceptibility and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus. J. Clin. Microbiol. 26:2626-2631.[Abstract/Free Full Text]
8
- National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility tests of yeasts. Approved standard M-27A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
9
- Pfaller, M. A., L. Burmeister, M. A. Bartlett, and M. G. Rinaldi. 1988. Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol. 26:1437-1441.[Abstract/Free Full Text]
10
- Rex, J., M. Pfaller, J. Galgiani, M. Bartlett, A. Espinel-Ingroff, M. Ghannoum, M. Lancaster, F. Odds, M. Rinaldi, T. Walsh, and A. Barry. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro and in vivo correlation data for fluconazole and itraconazole and Candida infections. Clin. Infect. Dis. 24: 235-247.[Medline]
11
- Sewell, D. L., M. A. Pfaller, and A. L. Barry. 1994. Comparison of broth macrodilution, broth microdilution, and E test antifungal susceptibility tests for fluconazole. J. Clin. Microbiol. 32:2099-2102.[Abstract/Free Full Text]
Antimicrobial Agents and Chemotherapy, June 2002, p. 1781-1784, Vol. 46, No. 6
0066-4804/02/$04.00+0 DOI: 10.1128/AAC.46.6.1781-1784.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Milici, M. E., Maida, C. M., Spreghini, E., Ravazzolo, B., Oliveri, S., Scalise, G., Barchiesi, F.
(2007). Comparison between Disk Diffusion and Microdilution Methods for Determining Susceptibility of Clinical Fungal Isolates to Caspofungin. J. Clin. Microbiol.
45: 3529-3533
[Abstract]
[Full Text]
-
Brown, S., Traczewski, M.
(2007). Quality Control Limits for Posaconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue. J. Clin. Microbiol.
45: 222-223
[Abstract]
[Full Text]
-
Ghannoum, M., Isham, N., Sheehan, D.
(2006). Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial.. J. Clin. Microbiol.
44: 2579-2580
[Abstract]
[Full Text]
-
Hassan, I A, Critten, P, Isalska, B, Denning, D W
(2006). Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England.. J. Clin. Pathol.
59: 759-763
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J., Sheehan, D. J.
(2006). Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing. Clin. Microbiol. Rev.
19: 435-447
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J., Rex, J. H., Espinel-Ingroff, A., Johnson, E. M., Andes, D., Chaturvedi, V., Ghannoum, M. A, Odds, F. C., Rinaldi, M. G., Sheehan, D. J., Troke, P., Walsh, T. J., Warnock, D. W.
(2006). Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints.. J. Clin. Microbiol.
44: 819-826
[Abstract]
[Full Text]
-
Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., Diekema, D. J.
(2005). Comparison of Results of Voriconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program. J. Clin. Microbiol.
43: 5208-5213
[Abstract]
[Full Text]
-
Pfaller, M. A., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J., Diekema, D. J.
(2004). Evaluation of the Etest Method Using Mueller-Hinton Agar with Glucose and Methylene Blue for Determining Amphotericin B MICs for 4,936 Clinical Isolates of Candida Species. J. Clin. Microbiol.
42: 4977-4979
[Abstract]
[Full Text]
-
Pfaller, M. A., Hazen, K. C., Messer, S. A., Boyken, L., Tendolkar, S., Hollis, R. J., Diekema, D. J.
(2004). Comparison of Results of Fluconazole Disk Diffusion Testing for Candida Species with Results from a Central Reference Laboratory in the ARTEMIS Global Antifungal Surveillance Program. J. Clin. Microbiol.
42: 3607-3612
[Abstract]
[Full Text]
-
Pfaller, M. A., Barry, A., Bille, J., Brown, S., Ellis, D., Meis, J. F., Rennie, R., Rinaldi, M., Rogers, T., Traczewski, M.
(2004). Quality Control Limits for Voriconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue. J. Clin. Microbiol.
42: 1716-1718
[Abstract]
[Full Text]
-
Pfaller, M. A., Boyken, L., Messer, S. A., Hollis, R. J., Diekema, D. J.
(2004). Stability of Mueller-Hinton Agar Supplemented with Glucose and Methylene Blue for Disk Diffusion Testing of Fluconazole and Voriconazole. J. Clin. Microbiol.
42: 1288-1289
[Abstract]
[Full Text]
-
Green, M., Martin, J. M., Barbadora, K. A., Beall, B., Wald, E. R.
(2004). Reemergence of Macrolide Resistance in Pharyngeal Isolates of Group A Streptococci in Southwestern Pennsylvania. Antimicrob. Agents Chemother.
48: 473-476
[Abstract]
[Full Text]
-
Pfaller, M. A., Messer, S. A., Boyken, L., Rice, C., Tendolkar, S., Hollis, R. J., Diekema, D. J.
(2004). Evaluation of the NCCLS M44-P Disk Diffusion Method for Determining Susceptibilities of 276 Clinical Isolates of Cryptococcus neoformans to Fluconazole. J. Clin. Microbiol.
42: 380-383
[Abstract]
[Full Text]
-
Girmenia, C., Pizzarelli, G., D'Antonio, D., Cristini, F., Martino, P.
(2003). In Vitro Susceptibility Testing of Geotrichum capitatum: Comparison of the E-Test, Disk Diffusion, and Sensititre Colorimetric Methods with the NCCLS M27-A2 Broth Microdilution Reference Method. Antimicrob. Agents Chemother.
47: 3985-3988
[Abstract]
[Full Text]
-
Odabasi, Z., Paetznick, V., Goldstein, B. P., Rex, J. H., Ostrosky-Zeichner, L.
(2003). Disk Diffusion-Based Methods for Determining Candida parapsilosis Susceptibility to Anidulafungin. Antimicrob. Agents Chemother.
47: 3018-3020
[Abstract]
[Full Text]
-
Barry, A., Bille, J., Brown, S., Ellis, D., Meis, J., Pfaller, M., Rennie, R., Rinaldi, M., Rogers, T., Traczewski, M.
(2003). Quality Control Limits for Fluconazole Disk Susceptibility Tests on Mueller-Hinton Agar with Glucose and Methylene Blue. J. Clin. Microbiol.
41: 3410-3412
[Abstract]
[Full Text]
-
Matar, M. J., Ostrosky-Zeichner, L., Paetznick, V. L., Rodriguez, J. R., Chen, E., Rex, J. H.
(2003). Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole. Antimicrob. Agents Chemother.
47: 1647-1651
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J., Boyken, L., Messer, S. A., Tendolkar, S., Hollis, R. J.
(2003). Evaluation of the Etest and Disk Diffusion Methods for Determining Susceptibilities of 235 Bloodstream Isolates of Candida glabrata to Fluconazole and Voriconazole. J. Clin. Microbiol.
41: 1875-1880
[Abstract]
[Full Text]
-
Pfaller, M. A., Diekema, D. J., Messer, S. A., Boyken, L., Hollis, R. J.
(2003). Activities of Fluconazole and Voriconazole against 1,586 Recent Clinical Isolates of Candida Species Determined by Broth Microdilution, Disk Diffusion, and Etest Methods: Report from The ARTEMIS Global Antifungal Susceptibility Program, 2001. J. Clin. Microbiol.
41: 1440-1446
[Abstract]
[Full Text]
-
Maxwell, M. J., Messer, S. A., Hollis, R. J., Boyken, L., Tendolkar, S., Diekema, D. J., Pfaller, M. A.
(2003). Evaluation of Etest Method for Determining Fluconazole and Voriconazole MICs for 279 Clinical Isolates of Candida Species Infrequently Isolated from Blood. J. Clin. Microbiol.
41: 1087-1090
[Abstract]
[Full Text]
-
Pfaller, J. B., Messer, S. A., Hollis, R. J., Diekema, D. J., Pfaller, M. A.
(2003). In Vitro Susceptibility Testing of Aspergillus spp.: Comparison of Etest and Reference Microdilution Methods for Determining Voriconazole and Itraconazole MICs. J. Clin. Microbiol.
41: 1126-1129
[Abstract]
[Full Text]